Persistent URL of this record https://hdl.handle.net/1887/114931
In Collections
This item can be found in the following collections:
![Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature
- All authors
- Melief, S.M.; Visconti, V.V.; Visser, M.; Diepen, M. van; Kapiteijn, E.H.W.; Berg, J.H. van den; Haanen, J.B.A.G.; Smit, V.T.H.B.M.; Oosting, J.; Burg, S.H. van der; Verdegaal, E.M.E.
- Date
- 2017-02-28
- Journal
- Cancer Immunology Research
- Volume
- 5
- Issue
- 2
- Pages
- 170 - 179